Literature DB >> 21298440

The endothelial microenvironment in the venous valvular sinus: thromboresistance trends and inter-individual variation.

W E Trotman1, D J Taatjes, P W Callas, E G Bovill.   

Abstract

The valve sinuses of the deep venous system are frequent sites of venous thrombus initiation. We previously reported that, in comparison with the non-valvular lumenal endothelium, the valve sinus endothelium had decreased expression of von Willebrand factor (vWF) and increased expression of endothelial protein C receptor (EPCR) and thrombomodulin (TM), suggesting alteration in the procoagulant/anticoagulant balance. We hypothesized that increased stasis in the deeper recesses of the venous valves would be associated with a gradient of increased thromboresistance. Expression of EPCR, TM, and vWF was analyzed via quantitative confocal immunofluorescence in residual saphenous veins collected following coronary artery bypass procedures. In agreement with our hypothesis, endothelial expression of vWF in the valve sinus decreased from the uppermost to the deepest region of the valve sinus. In contrast to our hypothesis, EPCR expression decreased from the uppermost to the deepest region of the valve sinus (p < 0.001) and TM expression remained unchanged throughout the valve sinus. Comparison of the non-valvular lumenal endothelium with the valve sinus endothelium demonstrated significantly decreased vWF expression (p < 0.001) in the valvular sinus consistent with our previous report; however, we did not observe statistically significant differences in EPCR or TM expression in this comparison. In addition, remarkable inter-individual variation in expression of these three proteins was also observed. These findings suggest that the genesis of these observations is more complex than predicted by our initial hypothesis, likely due, at least in part, to the complex rheology of the valvular sinus microenvironment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21298440      PMCID: PMC3149826          DOI: 10.1007/s00418-011-0783-5

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  23 in total

Review 1.  Risk factors for venous thrombotic disease.

Authors:  F R Rosendaal
Journal:  Thromb Haemost       Date:  1999-08       Impact factor: 5.249

Review 2.  The clinical implications of endothelial dysfunction.

Authors:  Michael E Widlansky; Noyan Gokce; John F Keaney; Joseph A Vita
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

3.  Endothelial cell diversity revealed by global expression profiling.

Authors:  Jen-Tsan Chi; Howard Y Chang; Guttorm Haraldsen; Frode L Jahnsen; Olga G Troyanskaya; Dustin S Chang; Zhen Wang; Stanley G Rockson; Matt van de Rijn; David Botstein; Patrick O Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-08       Impact factor: 11.205

Review 4.  The cytoprotective protein C pathway.

Authors:  Laurent O Mosnier; Berislav V Zlokovic; John H Griffin
Journal:  Blood       Date:  2006-11-16       Impact factor: 22.113

5.  Precipitating factors in venous thrombosis.

Authors:  J C PATERSON; J McLACHLIN
Journal:  Surg Gynecol Obstet       Date:  1954-01

Review 6.  What's wrong with Bonferroni adjustments.

Authors:  T V Perneger
Journal:  BMJ       Date:  1998-04-18

7.  Effect of anatomic variations on deep venous thrombosis of the lower extremity.

Authors:  G C Liu; E J Ferris; J R Reifsteck; M E Baker
Journal:  AJR Am J Roentgenol       Date:  1986-04       Impact factor: 3.959

Review 8.  Endothelial dysfunction: a marker of atherosclerotic risk.

Authors:  Piero O Bonetti; Lilach O Lerman; Amir Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-01       Impact factor: 8.311

9.  Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT).

Authors:  C Y Vossen; J Conard; J Fontcuberta; M Makris; F J M VAN DER Meer; I Pabinger; G Palareti; F E Preston; I Scharrer; J C Souto; P Svensson; I D Walker; F R Rosendaal
Journal:  J Thromb Haemost       Date:  2005-03       Impact factor: 5.824

10.  The structure and growth of valve-pocket thrombi in femoral veins.

Authors:  S Sevitt
Journal:  J Clin Pathol       Date:  1974-07       Impact factor: 3.411

View more
  6 in total

Review 1.  Recent progress in histochemistry and cell biology.

Authors:  Stefan Hübner; Athina Efthymiadis
Journal:  Histochem Cell Biol       Date:  2012-02-25       Impact factor: 4.304

2.  In focus in HCB.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2019-11       Impact factor: 4.304

3.  In silico analyses of blood flow and oxygen transport in human micro-veins and valves.

Authors:  Navaneeth Krishna Rajeeva Pandian; Abhishek Jain
Journal:  Clin Hemorheol Microcirc       Date:  2022       Impact factor: 2.411

4.  Microengineered Human Vein-Chip Recreates Venous Valve Architecture and Its Contribution to Thrombosis.

Authors:  Navaneeth Krishna Rajeeva Pandian; Brandon K Walther; Rishi Suresh; John P Cooke; Abhishek Jain
Journal:  Small       Date:  2020-11-17       Impact factor: 13.281

5.  Hemodynamic regulation of perivalvular endothelial gene expression prevents deep venous thrombosis.

Authors:  John D Welsh; Mark H Hoofnagle; Sharika Bamezai; Michael Oxendine; Lillian Lim; Joshua D Hall; Jisheng Yang; Susan Schultz; James Douglas Engel; Tsutomu Kume; Guillermo Oliver; Juan M Jimenez; Mark L Kahn
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

Review 6.  Flow control in our vessels: vascular valves make sure there is no way back.

Authors:  Eleni Bazigou; Taija Makinen
Journal:  Cell Mol Life Sci       Date:  2012-08-25       Impact factor: 9.261

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.